Finance

Beta
Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
₹3,077.00
+1.98%
(+59.80) 1D
Jun 10, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
₹3,040.80
High
₹3,089.20
Low
₹2,982.00
Mkt. cap
383.86B
Avg. vol.
140.66K
Volume
182.47K
Dividend
1.36%
Quarterly dividend
₹10.50
Ex-dividend date
Nov 10, 2025
P/E ratio
36.41
52-wk high
₹3,314.90
52-wk low
₹2,329.90
EPS
₹84.51
Shares outstanding
88.45M
No. of employees
10K
Open
₹3,040.80
High
₹3,089.20
Low
₹2,982.00
Mkt. cap
383.86B
Avg. vol.
140.66K
Volume
182.47K
Dividend
1.36%
Quarterly dividend
₹10.50
Ex-dividend date
Nov 10, 2025
P/E ratio
36.41
52-wk high
₹3,314.90
52-wk low
₹2,329.90
EPS
₹84.51
Shares outstanding
88.45M
No. of employees
10K
News stories
From sources across the web
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees9.63K
Founded1973
Headquarters-
SectorPharmaceutical industry
Websiteajantapharma.com
Last report
May 5, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹21.34 / ₹20.34
+4.93%beat
Revenue / Est. (INR)
14.22B / 13.27B
+7.10%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.03B
13.54B
13.75B
14.22B
Cost of goods sold
2.76B
3.17B
2.86B
3.05B
Cost of revenue
2.76B
3.17B
2.86B
3.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.03B
3.17B
3.31B
3.41B
Operating expense
6.92B
7.11B
7.50B
7.87B
Total operating expenses
9.67B
10.28B
10.36B
10.92B
Operating income
3.35B
3.26B
3.39B
3.30B
Other non operating income
169.50M
197.10M
164.20M
170.60M
EBT including unusual items
3.31B
3.41B
3.59B
3.47B
EBT excluding unusual items
3.31B
3.41B
3.59B
3.47B
Income tax expense
757.90M
806.20M
848.30M
804.10M
Effective tax rate
22.89%
23.66%
23.66%
23.17%
Other operating expenses
3.47B
3.51B
3.76B
4.01B
Net income
2.55B
2.60B
2.74B
2.67B
Net profit margin
19.60%
19.22%
19.91%
18.76%
Earnings per share
20.43
20.82
21.91
21.34
Interest and investment income
-
-
-
-
Interest expense
-52.60M
-33.90M
-51.00M
-23.60M
Net interest expenses
-52.60M
-33.90M
-51.00M
-23.60M
Depreciation and amortization charges
412.90M
429.70M
435.10M
453.70M
EBITDA
3.66B
3.68B
3.70B
3.73B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer